Gary Morgan, CDT, CQA/ASQ, looks at how labs are fearlessly entering into activities that place them under FDA’s regulatory authority. He explores future regulatory oversight including changes in FDA’s Quality System regulations and discusses how a digitized eQMS improves collaboration, communication and efficiency.